SEARCH

SEARCH BY CITATION

References

  • ASAKO, H., KUBES, P., WALLACE, J.L., WOLF, R.E. & GRANGER, D.N. (1992). Modulation of leukocyte adherence in rat mesenteric venules by aspirin and salicylate. Gastroenterology, 103, 146152.
  • BISHOP-BAILEY, D., BURKE-GAFFNEY, A., HELLEWELL, P.G., PEPPER, J.R. & MITCHELL, J.A. (1998). Cyclo-oxygenase-2 regulates inducible ICAM-1 and VCAM-1 expression in human vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 249, 4447.
  • BOYCE, S., CHAN, C.C., GORDON, R., LI, C.-S., RODGER, I.W., WEBB, J.K., RUPNIAK, N.M.J. & HILL, R.G. (1994). L-745,337: A selective inhibitor of cyclooxygenase-2 elicits antinociception but not gastric ulceration in rats. Neuropharmacology, 33, 16091611.
  • BUNTING, S., MONCADA, S. & VANE, J.R. (1983). The prostacyclin–thromboxane A2 balance: pathophysiological and therapeutic implications. Br. Med. Bull., 39, 271276.
  • CATELLA-LAWSON, F., MCADAM, B., MORRISON, B.W., KAPOOR, S., KUJUBU, D., ANTES, L., LASSETER, K.C., QUAN, H., GERTZ, B.J. & FITZGERALD, G.A. (1999). Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J. Pharmacol. Exp. Ther., 289, 735741.
  • DE NUCCI, G., THOMAS, R., D'ORLEANS-JUSTE, P., ANTUNES, E., WALDER, C., WARNER, T.D. & VANE, J.R. (1988). Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin. Proc. Natl. Acad. Sci. U.S.A., 85, 97979800.
  • EDWARDS, J.C.W., SEDGWICK, A.D. & WILLOUGHBY, D.A. (1981). The formation of a structure with features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system. J. Pathol., 134, 147156.
  • FLOWER, R.J. & VANE, J.R. (1972). Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamide-phenol). Nature New Biol., 240, 410411.
  • HARDING, P., SIGMON, D.H., ALFIE, M.E., HUANG, P.L., FISHMAN, M.C., BEIERWALTES, W.H. & CARRETERO, O.A. (1997). Cyclooxygenase-2 mediates increased renal content induced by low-sodium diet. Hypertension, 29, 297302.
  • HARRIS, R.C., MCKANNA, J.A., AKAI, Y., JACOBSON, H.R. & DUBOIS, R.N. (1994). Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J. Clin. Invest., 94, 25042510.
  • KOMHOFF, M., GRONE, H.J., KLEIN, T., SEYBERTH, H.W. & NUSING, R.M. (1997). Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am. J. Physiol., 272, F460F468.
  • KUBES, P., SUZUKI, M. & GRANGER, D.N. (1991). Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U.S.A., 88, 46514655.
  • KUJUBU, D.A., FLETCHER, B.S., VARNUM, B.C., LIM, R.W. & HERSCHMAN, H.R. (1991). TIS10, a phorbol ester tumor promoter-inducible mRNA from swiss eTe cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem., 266, 1286612872.
  • MCADAM, B.F., CATELLA-LAWSON, F., MARDINI, I.A., KAPOOR, S., LAWSON, J.A. & FITZGERALD, G.A. (1999). Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2. Proc. Natl. Acad. Sci. U.S.A., 96, 272277.
  • MIZUNO, H., SAKAMOTO, C., MATSUDA, K., WADA, K., UCHIDA, T., NOGUCHI, H., AKAMATSU, T. & KASUGA, M. (1997). Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology, 112, 387397.
  • MUSCARÁ, M.N. & DE NUCCI, G. (1996). Simultaneous determination of nitrite and nitrate anions in plasma, urine and cell culture supernatants by high-performance liquid chromatography with post column reactions. J. Chromatogr. B Biomed. Appl., 686, 157164.
  • MUSCARÁ, M.N., MCKNIGHT, W., DEL SOLDATO, P. & WALLACE, J.L. (1998). Effect of a nitric oxide-releasing naproxen derivative on hypertension and gastric damage induced by chronic nitric oxide inhibition in the rat. Life Sci., 62, PL235PL240.
  • RADOMSKI, M. & MONCADA, S. (1983). An improved method for washing of human platelets with prostacyclin. Thromb. Res., 30, 383389.
  • REUTER, B.K., ASFAHA, S., BURET, A., SHARKEY, K.A. & WALLACE, J.L. (1996). Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J. Clin. Invest., 98, 20762085.
  • SEDGWICK, A.D., MOORE, A.R., AL-DUAIJ, A.Y., EDWARDS, J.C. & WILLOUGHBY, D.A. (1985). Studies into the influence of carrageenan-induced inflammation on articular cartilage degradation using implantation into air pouches. Br. J. Exp. Pathol., 66, 445453.
  • SEIBERT, K., ZHANG, Y., LEAHY, K., HAUSER, S., MASFERRER, J. & ISAKSON, P. (1997). Distribution of COX-1 and COX-2 in normal and inflamed tissues. Adv. Exp. Med. Biol., 400, 167170.
  • SEIBERT, K., ZHANG, Y., LEAHY, K., HAUSER, S., MASFERRER, J., PERKINS, W., LEE, L. & ISAKSON, P. (1994). Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. U.S.A., 91, 1201312017.
  • SIMON, L.S., LANZA, F.L., LIPSKY, P.E., HUBBARD, R.C., TALWALKER, S., SCHWARTZ, B.D., ISAKSON, P.C. & GEIS, G.S. (1998). Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor - Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum., 41, 15911602.
  • SMITH, C.J., ZHANG, Y., KOBOLDT, C.M., MUHAMMAD, J., ZWEIFEL, B.S., SHAFFER, A., TALLEY, J.J., MASFERRER, J.L., SEIBERT, K. & ISAKSON, P.C. (1998). Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc. Natl. Acad. Sci. U.S.A., 95, 1331313318.
  • VANE, J.R. (1994). Towards a better aspirin. Nature, 367, 215216.
  • VANE, J.R., MITCHELL, J.A., APPLETON, I., TOMLINSON, A., BISHOP-BAILEY, D., CROXTALL, J. & WILLOUGHBY, D.A. (1994). Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. U.S.A., 91, 20462050.
  • WALLACE, J.L. (1999). Selective COX-2 inhibitors: is the water becoming muddy Trends Pharmacol. Sci., 20, 46.
  • WALLACE, J.L., CHAPMAN, K. & MCKNIGHT, W. (1999). Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation. Br. J. Pharmacol., 126, 12001204.
  • WALLACE, J.L., MCKNIGHT, W., MIYASAKA, M., TAMATANI, T., PAULSON, J., ANDERSON, D.C., GRANGER, D.N. & KUBES, P. (1993). Role of endothelial adhesion molecules in NSAID-induced gastric mucosal injury. Am. J. Physiol., 265, G993G998.
  • WANG, J.L., CHENG, H.R. & HARRIS, R.C. (1999). Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension. Hypertension, 34, 96101.
  • XIE, W., CHIPMAN, J.G., ROBERTSON, D.L., ERIKSON, R.L. & SIMMONS, D.L. (1991). Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci., 88, 26922696.
  • XIE, W., ROBERTSON, D.L. & SIMMONS, D.L. (1992). Mitogen-inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugs. Drug Dev. Res., 25, 249265.